Stay updated with breaking news from Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price among […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 117,372 shares of the stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $11.91, for a total value of $1,397,900.52. Following the sale, the chief operating officer now directly owns 627,918 shares in the company, […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 16,397 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $11.86, for a total transaction of $194,468.42. Following the completion of the sale, the chief operating officer now directly […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 73,568 shares of the stock in a transaction on Wednesday, July 26th. The shares were sold at an average price of $10.91, for a total value of $802,626.88. Following the sale, the chief operating officer now directly owns 627,918 shares in the company, […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 33,081 shares of Roivant Sciences stock in a transaction on Monday, July 24th. The stock was sold at an average price of $10.93, for a total transaction of $361,575.33. Following the transaction, the chief operating officer now directly owns 644,215 shares of the […]